Skip to content

Author

P. Cullis

We have 4 of 40 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Nov 2026

Engineering mRNA-Lipid nanoparticle (LNP) vaccines against multidrug resistant bacteria: current and future prospects.

This review highlights the significant potential of mRNA-lipid nanoparticle (LNP) technology for application in bacterial vaccines, with a long-term goal to provide critical tools in controlling problematic microbial infections regardless of their antimicrobial resistance (AMR) profile. The current landscape of bacteri...

Olga Pacios Santamaría, M. M. Khan, Ehsan Ansari Dezfouli et al. · 0 citations
Open access Sep 2026

Increasing Lipid Nanoparticle mRNA Copy Number Improves Transfection Potency.

Lipid nanoparticles (LNPs) are the leading platform for delivery of RNA-based therapeutics. There is considerable interest in optimizing the transfection potency of these systems. Standard formulation protocols involve mixing lipids in ethanol with a buffer containing mRNA at pH 4, followed by dialysis against a pH 7.4...

Yao Zhang, Jerry Leung, Judy Cheng et al. · 0 citations
Sep 2026

Programmable mRNA Nanotherapeutics through Logic Switch Design

A quantitative framework based on five key performance dimensions: dynamic range, temporal kinetics, output efficiency, spatial fidelity, and cycle retention is proposed, which discusses the emerging roles for computational modeling and artificial intelligence in enabling multiobjective optimization of these metrics an...

Pengwen Chen, Abdulaziz Alhussan, P. Cullis et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.